Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 24;28(1):253.
doi: 10.1186/s40001-023-01212-5.

French recommendations for the management of glycogen storage disease type III

Camille Wicker  1 , Aline Cano  2 , Valérie Decostre  3 , Roseline Froissart  4 , François Maillot  5 , Ariane Perry  6 , François Petit  7 , Catherine Voillot  6 , Karim Wahbi  8 , Joëlle Wenz  9 , Pascal Laforêt  10 , Philippe Labrune  11
Affiliations
Review

French recommendations for the management of glycogen storage disease type III

Camille Wicker et al. Eur J Med Res. .

Abstract

The aim of the Protocole National De Diagnostic et de Soins/French National Protocol for Diagnosis and Healthcare (PNDS) is to provide advice for health professionals on the optimum care provision and pathway for patients with glycogen storage disease type III (GSD III).The protocol aims at providing tools that make the diagnosis, defining the severity and different damages of the disease by detailing tests and explorations required for monitoring and diagnosis, better understanding the different aspects of the treatment, defining the modalities and organisation of the monitoring. This is a practical tool, to which health care professionals can refer. PNDS cannot, however, predict all specific cases, comorbidities, therapeutic particularities or hospital care protocols, and does not seek to serve as a substitute for the individual responsibility of the physician in front of his/her patient.

PubMed Disclaimer

Conflict of interest statement

All authors report no competing interests.

Figures

Fig. 1
Fig. 1
Simplified glycogen metabolism: synthesis and degradation cycle and consequences in cases of debranching enzyme deficiency
See this image and copyright information in PMC

References

    1. Kishnani PS, Austin SL, Arn P, Bali DS, Boney A, Case LE, et al. Glycogen storage disease type III diagnosis and management guidelines. Genet Med. 2010;12(7):446–463. doi: 10.1097/GIM.0b013e3181e655b6. - DOI - PubMed
    1. Dagli A, Sentner CP, Weinstein DA. Glycogen Storage Disease Type III. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, et al., editors. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993. http://www.ncbi.nlm.nih.gov/books/NBK26372/. Accessed 17 Apr 2020.
    1. Sentner CP, Hoogeveen IJ, Weinstein DA, Santer R, Murphy E, McKiernan PJ, et al. Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome. J Inherit Metab Dis. 2016;39(5):697–704. doi: 10.1007/s10545-016-9932-2. - DOI - PMC - PubMed
    1. Berling E, Laforêt P, Wahbi K, Labrune P, Petit F, Ronzitti G, O’Brien A. Narrative review of glycogen storage disorder type III with a focus on neuromuscular, cardiac and therapeutic aspects. J Inherit metab Dis. 2021;44:521–533. doi: 10.1002/jimd.12355. - DOI - PubMed
    1. Michon C-C, Gargiulo M, Hahn-Barma V, Petit F, Nadaj-Pakleza A, Herson A, et al. Cognitive profile of patients with glycogen storage disease type III: a clinical description of seven cases. J Inherit Metab Dis. 2015;38(3):573–580. doi: 10.1007/s10545-014-9789-1. - DOI - PubMed

LinkOut - more resources